Press release
Constipation Treatment Market is predicted to procure USD 10.1 Bn by 2032, Grow at a CAGR of 5.6% | Abbott, Sanofi, Bayer AG, AstraZeneca plc., Ironwood Pharmaceuticals.
The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.
Key Takeaways:
The laxative segment to maintain its leadership status throughout the forecast period.
The chronic idiopathic constipation segment to maintain its leadership status throughout the forecast period.
The prescribed drugs segment to maintain its leadership status throughout the forecast period.
North America to maintain its dominance by 2032.
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/8560
Major Factors Driving the Growth of Constipation Treatment Market:
Increasing prevalence of constipation: Constipation is a common problem that affects millions of people worldwide. The prevalence of constipation is increasing due to a number of factors, including aging, sedentary lifestyles, and poor diet.
Rising demand for over-the-counter (OTC) constipation treatments: OTC constipation treatments are becoming increasingly popular due to their convenience and affordability. OTC constipation treatments include laxatives, stool softeners, and fiber supplements.
Growing awareness of prescription constipation treatments: Prescription constipation treatments are becoming more widely known and accepted, as they can be more effective than OTC treatments for chronic or severe constipation. Prescription constipation treatments include prucalopride, linaclotide, and lubiprostone.
Increasing investment in research and development: Pharmaceutical companies are investing heavily in the research and development of new and more effective constipation treatments. This is leading to the development of new drugs and devices that can help to improve the symptoms and quality of life for people with constipation.
Drivers:
Rise in prevalence of Chronic disease such as chronic pain and cancer
High presence of constipation drug manufacturers
Increase in number of geriatric populations
Opportunities:
Rise in adoption of number of strategies by market players of constipation treatment drugs
Restraints:
Alternative options available for constipation treatment
Market Segmentation:
Product type:
Laxatives: Laxatives are the most common type of constipation treatment. They work by increasing the amount of water in the stool or by stimulating the muscles of the colon to contract. Laxatives can be further segmented into:
Stool softeners: Stool softeners work by increasing the water content of the stool and making it easier to pass.
Fiber supplements: Fiber supplements work by adding bulk to the stool and helping it to move through the digestive system more easily.
Other constipation treatments: Other constipation treatments include prescription medications, biofeedback therapy, and surgery.
Application:
Chronic idiopathic constipation (CIC): CIC is the most common type of constipation. It is characterized by infrequent bowel movements and hard stools.
Irritable bowel syndrome with constipation (IBS-C): IBS-C is a type of irritable bowel syndrome that is characterized by abdominal pain, cramping, bloating, and constipation.
Opioid-induced constipation (OIC): OIC is a type of constipation that is caused by the use of opioid pain medications.
Other applications: Constipation treatments are also used to treat other conditions such as hemorrhoids, anal fissures, and diverticular disease.
End user:
Over-the-counter (OTC) constipation treatments: OTC constipation treatments are available without a prescription and can be purchased from pharmacies and grocery stores.
Prescription constipation treatments: Prescription constipation treatments are available with a prescription from a doctor.
Other end users: Other end users of constipation treatments include hospitals, clinics, and nursing homes.
Geography:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Europe)
LAMEA (Brazil, South Africa,, Saudi Arabia, Rest of LAMEA)
Request for Customization: https://www.alliedmarketresearch.com/request-for-customization/8560
Regional Growth Dynamics:
North America held the highest market share in terms of revenue in 2022, accounting for around two-fifths of the global constipation treatment market revenue. This is attributed to the high presence of constipation treatment drug manufacturers in North America and rising prevalence of chronic diseases such as cancer and chronic pain. However, the Asia-Pacific region is expected to witness the fastest CAGR of 6.4% from 2023 to 2032 and is likely to dominate the market during the forecast period, owing to rising number of geriatric populations, as geriatric population is more susceptible to chronic diseases such as constipation, chronic pain and others and increase in awareness among the people regarding constipation treatment.
Competitive Landscape
The key players in the global constipation treatment market are:
Takeda Pharmaceutical Company Ltd.
Abbvie Inc.
Abbott Laboratories
Sanofi S.A.
Bausch Health Companies Inc.
Bayer Ag
Astrazeneca Plc
Ironwood Pharmaceuticals, Inc.
Prestige Consumer Healthcare Inc.
Ardelyx Inc.
Recent developments:
In May 2023, Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, and VectivBio, a clinical-stage biopharmaceutical company, announced that they have entered into a definitive agreement for Ironwood to acquire VectivBio. This acquisition pioneered novel treatments for severe rare gastrointestinal diseases such as constipation.
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/8560
Browse more latest healthcare reports:
Smoke Evacuation Systems Market https://www.alliedmarketresearch.com/smoke-evacuation-systems-market-A10370
Laser Therapy Devices Market: https://www.alliedmarketresearch.com/laser-therapy-devices-market-A10862
Nuclear Medicine Equipment Market: https://www.alliedmarketresearch.com/nuclear-medicine-equipment-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Constipation Treatment Market is predicted to procure USD 10.1 Bn by 2032, Grow at a CAGR of 5.6% | Abbott, Sanofi, Bayer AG, AstraZeneca plc., Ironwood Pharmaceuticals. here
News-ID: 3383732 • Views: …
More Releases from Allied Market Research
NFC Payments to Skyrocket from $25.8B in 2022 to $507.1B by 2032, Report Show
Allied Market Research has recently published a report, titled, "NFC Payments Market by Device Type (Smartphones, Smartwatches, Tablets, EMV Cards, Others), by End User (Retail Stores, Hospitality, Healthcare Services, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global NFC payments market generated $25.8 billion in 2022, and is anticipated to generate $507.1 billion by 2032, witnessing a CAGR of 35.9% from 2023 to 2032.
Request Research…
(At a 32.5% CAGR) | AI in BFSI Market Expected to Reach $368.6 Billion by 2032
Allied Market Research published a report, titled, "Artificial Intelligence in BFSI Market by Offering (Hardware, Software, and Services), Solution (Chatbots, Fraud Detection & Prevention, Anti-Money Laundering, Customer Relationship Management, Data Analytics & Prediction, and Others), and Technology (Machine Learning, Natural Language Processing, Computer Vision, and Others): Global Opportunity Analysis and Industry Forecast, 2022-2032". According to the report, the global artificial intelligence in BFSI industry generated $ 22.5 billion in 2022,…
Automated Teller Machine Market to Reach $ 50 billion by 2032 at 8.6% CAGR | Die …
Allied Market Research published a report, titled, "Automated Teller Machine Market by Type (Conventional/bank, Brown ATMs, White ATMs, Cash Dispenser, and Smart ATMS), and Deployment (Onsite ATMs, Offsite ATMs, Worksite ATMs, and Mobile ATMs): Global Opportunity Analysis and Industry Forecast, 2022-2032. According to the report, the global automated teller machine industry generated $ 22.6 billion in 2022, and is anticipated to generate $ 50 billion by 2032, witnessing a CAGR…
U.S. Employee Benefits Insurance Brokerage Market to Reach USD 70.11 Billion by …
The U.S. insurance brokerage for employee benefits market encompasses a sector within the broader insurance industry that specializes in assisting employers in the design, procurement, and management of employee benefits programs. These programs typically include health insurance, retirement plans, life insurance, disability coverage, and an array of supplementary benefits such as wellness initiatives and financial planning services. Insurance brokers in this market act as intermediaries between employers seeking to provide…
More Releases for Constipation
Major Growth Driver Identified in 2025 Constipation Laxative Market: Increasing …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Constipation Laxative Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for constipation laxatives has experienced robust growth in the past few years. An upturn from $7 billion in 2024 to $7.37 billion in 2025, achieving a compound annual growth rate (CAGR) of…
Evolving Market Trends In The Opioid-Induced Constipation Treatment Industry: St …
The Opioid-Induced Constipation Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Opioid-Induced Constipation Treatment Market Size During the Forecast Period?
The opioid-induced constipation treatment market, valued at $1.78 billion in 2024, is projected to increase to $1.9 billion in 2025, growing…
Key Trends Shaping the Future Constipation Laxative Market From 2025-2034: Innov …
How Are the key drivers contributing to the expansion of the constipation laxative market?
The rising prevalence of constipation is expected to boost the growth of the constipation laxative market. Constipation, characterized by infrequent or difficult bowel movements, is becoming more common due to changes in diet, sedentary lifestyles, inadequate fluid intake, and medical conditions. Constipation laxatives help relieve this condition by stimulating bowel movements or softening stools. A 2024 survey…
Leading Element Driving Change in the Constipation Laxative Market in 2025: Incr …
What Is the Estimated Market Size and Growth Rate for the Constipation Laxative Market?
The market for constipation laxatives has seen substantial expansion in the past few years. It is projected to further expand from $7 billion in 2024 to $7.44 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the historical period include an increase in the elderly population, sedentary lifestyles,…
[Latest] Constipation Treatment Market : An Overview
The ""Constipation Treatment Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Constipation Treatment Market, 2024-2031
Verified Market Research's most recent report, ""Constipation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,"" provides an in-depth…
How to Improve Constipation - Cassia Fistula Extract
Cassia Fistula Extract is a natural plant ingredient extracted from the friut of the Cassia Fistula tree and is widely used in traditional Chinese medicine and modern medicine.
Here are some common applications of Cassia Fistula Extract [https://www.ie-extract.com/cassia-fistula-extract-cassia-fistula-extract-treatment-of-constipation-product/]:
Promotes bowel movement and relieves constipation: Cassia Fistula Extract is believed to promote bowel movement and relieve constipation. Research shows that its active ingredients can stimulate intestinal motility, increase bowel movement frequency, and improve…
